Actinomycin D is the first discovery of antibiotics with strong antineoplastic activity. Owing to extreme toxicity, its clinical application as chemotherapeutics has been limited to the treatment of malignant tumors. This review outlines the structural characteristics of natural actinomycins and focuses on actinomycin biosynthesis including kynurenine pathway,nonribosomal petide synthesis pathway and phenoxazone chromophore formation. Progress on the biosynthesis of actinomycins is conducive to the development of new low toxicity structural analogs of actinomycins.